A major pharmaceutical company which alleges trademark infringement has been refused an injunction preventing the roll-out by a rival of an inhaler for asthmatics. The injunction was sought pending ...

The New England Journal of Medicine has published a clinical trial showing that Novartis' Ultibro Breezhaler outshone GlaxoSmithKline's Seretide on reducing COPD flare-ups, which could challenge the ...

A major pharmaceutical company has claimed alleged infringement of its trademark entitles it to an injunction preventing the roll-out by a rival of an inhaler for asthmatics. GlaxoSmithKline (GSK) ...

Mumbai: Glenmark Pharmaceuticals Ltd said on Friday that it has received regulatory approval for the generic version of GlaxoSmithKline Plc’s Seretide Accuhaler in the Nordic region, which includes ...

Enters the inhaler market in Russia with approval of Salmecort MDI inhaler Glenmark Pharmaceuticals has received approval for Salmecort (Salmeterol+Fluticasone) MDI inhaler, from the Ministry of ...

(Reuters) - Vectura Group said on Friday a British court had ruled in its favor on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline. Vectura said the court ...

A SMALL tear could help identify if your asthma inhaler is one of thousands recalled amid fears thousands are “putting sufferers’ lives at risk”. Two brands of inhalers have been found to be faulty, ...